Transcatheter edge-to-edge repair (TEER) is feasible and clinically beneficial for treating tricuspid regurgitation in selected patients with repaired tetralogy of Fallot.
Is transcatheter tricuspid valve edge-to-edge repair feasible and clinically beneficial in patients with repaired Tetralogy of Fallot and tricuspid regurgitation?
Transcatheter tricuspid edge-to-edge repair is a feasible and clinically beneficial option for managing tricuspid regurgitation in selected patients with repaired Tetralogy of Fallot.
TR contributes to right heart failure in rTOF. The tricuspid subvalvular apparatus may be fragile; nevertheless, TEER remains feasible and clinically beneficial in selected patients.
Azizi et al. (2026) studied this question. Transcatheter edge-to-edge repair (TEER) is feasible and clinically beneficial for treating tricuspid regurgitation in selected patients with repaired tetralogy of Fallot.